^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    LY007

    i
    Other names: LY007, CD20 CAR-T cells, CD20 CAR-T cells therapy
    Associations

    News

    Trials
    Company:
    China Biotech Services
    Drug class:
    CD20-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    25d
    An Evaluation of LY007 Cell Injection for r/r B-NHL (clinicaltrials.gov)
    P1, N=18, Recruiting, Ruijin Hospital
    New P1 trial
    |
    CD20 (Membrane Spanning 4-Domains A1)
    |
    CD20 expression
    |
    LY007
    2ms
    An Evaluation of LY007 Cell Injection for r/r B-NHL (clinicaltrials.gov)
    P1, N=18, Recruiting, Shanghai Longyao Biotechnology Inc., Ltd.
    New P1 trial
    |
    CD20 (Membrane Spanning 4-Domains A1)
    |
    CD20 expression
    |
    LY007